Abstract:Background: Intraductal papillary neoplasm of the bile duct (IPNB) is a rare distinct subtype of precursor lesions of biliary carcinoma. IPNB is considered to originate from luminal biliary epithelial cells, typically displays mucin-hypersecretion or a papillary growth pattern, and results in cystic dilatation[1]. IPNB develops anywhere in the intrahepatic and extrahepatic biliary tracts, and can occur in various pathological stages from low-grade dysplasia to invasive carcinoma. IPNBs have similar phenotypic changes in the occurrence and development of all subtypes, and the prognosis is significantly better than that of traditional (non-papillary) cholangiocarcinoma. Aim: To evaluate the clinicopathological features of IPNB to provide evidence-based guidance for treatment. Methods: Invasive IPNB, invasive intraductal papillary mucinous neoplasm of the pancreas (IPMN), and traditional cholangiocarcinoma data for affected individuals from 1975 to 2016 were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Annual percentage changes (APCs) in the incidence and incidence-based (IB) mortality were calculated. We identified the independent predictors of overall survival (OS) and cancer-specific survival (CSS) in individuals with invasive IPNB. Results: The incidence and IB mortality of invasive IPNB showed sustained decreases, with an APC of -4.5% (95%CI: -5.1% to -3.8%) and -3.3% (95%CI: -4.1% to -2.6%) (P < 0.001), respectively. Similar decreases in incidence and IB mortality were seen for invasive IPMN but not for traditional cholangiocarcinoma. Both OS and CSS for invasive IPNB were better than for invasive IPMN and traditional cholangiocarcinoma. A total of 1635 individuals with invasive IPNB were included in our prognosis analysis. The most common tumor sites were the pancreaticobiliary ampulla (47.9%) and perihilar tract (36.7%), but the mucin-related subtype of invasive IPNB was the main type, intrahepatically (approximately 90%). In the univariate and multivariate Cox regression analysis, age, tumor site, grade and stage, subtype, surgery, and chemotherapy were associated with OS and CSS (P < 0.05). Conclusion: Incidence and IB mortality of invasive IPNB trended steadily downward. The heterogeneity of IPNB comprises site and the tumor's mucin-producing status.

Long-term Outcome of Primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) Including PUNLMP with Inverted Growth.

The Pathologic and Clinic Characteristics of Papillary Urothelial Neoplasm with Low Malignant Potential

Inverted Papilloma of Urinary Bladder:A Clinicopathological Study of 60 Cases

[Inverted Urothelial Papilloma: Report of 151 Cases].

Local Tumor Progression After Ultrasound-Guided Percutaneous Microwave Ablation Of Stage T1a Renal Cell Carcinoma: Risk Factors Analysis Of 171 Tumors

Outcome Analysis of a Series of Mixed-Grade, Non-muscle Invasive, Papillary Carcinomas of the Bladder

Treatment and Outcomes of Primary Urethral Cancer.

Upper urinary tract inverted papillomas: Report of 10 cases.

Inverted Urothelial Papilloma (report of 113 Cases)

Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases

Outcome Determining Factors of Intraductal Papillary Neoplasm of the Biliary Tract (IPNB)—a Single Center Survey and Analysis of Current Literature

Pre-emptive resection for intraductal papillary mucinous neoplasia - Long-term outcome is similar between non-invasive and early invasive lesions in a tertiary single center

Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC)

Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: A nationwide retrospective study

Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct

Positive Surgical Margins After Partial Nephrectomy For Renal Cell Carcinoma: A Systematic Review And Meta-Analysis

Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status: Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance

Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic Ductal Adenocarcinoma: An Analysis from the German Cancer Registry Group of the Society of German Tumor Centers

Long-term survival after resection of invasive pancreatic intraductal papillary mucinous neoplasm

Urothelial Papilloma of the Bladder(Clinicopathological Study of 32 Cases)

Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series